Journal
Journal for ImmunoTherapy of Cancer
Publication Date
3-6-2026
Volume
14
Issue
3
First Page
e012222
Document Type
Open Access Publication
DOI
10.1136/jitc-2025-012222
Rights and Permissions
Monti M, Picinoli S, Bozzola A, Ferrari M, Bugatti M, Pezzali I, Carlomagno M, Carta G, Orlandi M, Lora G, Benerini Gatta L, Missale F, Ferrari G, Baldazzi V, Rezzola S, Tabellini G, Parolini S, Manfredi M, De Giorgis V, Marengo E, Turri-Zanoni M, Nicolai P, Consoli F, Lombardi D, Martini P, Li J, Griffith O, Griffith M, Rossato M, Vermi W. Integrating interferon gamma receptor pathways, antigenicity, and immune contexture as predictors of immunotherapeutic strategies for mucosal melanomas. J Immunother Cancer. 2026 Mar 6;14(3):e012222. doi: 10.1136/jitc-2025-012222. © 2026, The Author(s). Published by BMJ Publishing Group Ltd. on behalf of Society for Immunotherapy of Cancer. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See https://creativecommons.org/licenses/by-nc/4.0/.
Recommended Citation
Monti, Matilde; Li, Jinglun; Griffith, Obi; Griffith, Malachi; Vermi, William; and et al., "Integrating interferon gamma receptor pathways, antigenicity, and immune contexture as predictors of immunotherapeutic strategies for mucosal melanomas." Journal for ImmunoTherapy of Cancer. 14, 3. e012222 (2026).
https://digitalcommons.wustl.edu/oa_4/7133
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
